We’re pleased to announce that we are using Fluent Technology’s Flexigrant software for all new applications and post-grant management. We’re currently accepting applications for small and large project grants. Please download and read the guidelines for the scheme before making an application. All applications must be made through our application portal.
- New hope for cancer patient treatment, with targeted and selective chemotherapy delivery
- Statins synergise with a MEK-inhibitor to achieve a robust anti-tumour effect
- Advancing knowledge of Alzheimer’s disease, towards novel therapies
- A faster increase in ‘CAG’ repeats tends to give rise to early onset Huntington disease
- Investigating molecular targets for auditory system regeneration